Nr 546 week 7 - Study guides, Class notes & Summaries

NR 546 WEEK 7 ADHD Medication Table. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediateacting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulatio...

NR 546 Week 7 Case Study: Child and Adolescent (Solved). Subjective Objective The client is a 7-year-old male accompanied by his mother and 9-year-old brother. Client’s Chief Complaints: “My son has endless energy, he can’t sit still. When he plays, he is too rough with other kids.” History of Present Illness This clint was previously diagnosed with attentiondeficit/hyperactivity disorder (ADHD). The school reports that he cannot stay seated, frequently calls out in class, is d...

Chamberlain NR 546 Week 7 ADHD Medication Table

Chamberlain NR 546 Week 7 Review powerpoint

NR546 week 7 / NR 546 WEEK 7 test your knowledge quiz EXAM 2024 A 27-year-old bartender was diagnosed with ADHD at age 10. She has been on and off medication since then, first on immediate-release methylphenidate, then on the methylphenidate patch. She experimented with illicit drugs during her late adolescence and is still a heavy drinker. After a few years of self-medication with alcohol and cigarettes, she is seeking medical attention again. You decide to put her on 80 mg/day of atomoxetine,...

NR546 | NR 546 Week 7 | Psychopharmacology for the Psychiatric | Study Guide 2024 Guide NR546 | NR 546 Week 7 | Psychopharmacology for the Psychiatric | Study Guide 2024 Guide